All Articles
Wearable Biosensors Stocks: The Guide to Health Technology as Investment
Stocks10 min read

Wearable Biosensors Stocks: The Guide to Health Technology as Investment

By Redaktion aktie.com · Reviewed by Martin Schülbe

This article was created with the help of artificial intelligence.

Wearable Biosensors Stocks: The Guide to Health Technology as Investment

Wearable biosensors stocks are shares in publicly listed companies that develop, manufacture, or distribute wearable devices for continuous health monitoring. These sensors measure heart rate, blood glucose, oxygen saturation, and blood pressure in real time. The global market was approximately 31.6 billion US dollars in 2024 and is expected to grow to approximately 66.2 billion US dollars by 2034, at an annual growth rate between 7.7 and 8.2 percent.

What Wearable Biosensors Technically Deliver

A biosensor converts a biological signal into measurable electronic data. Placed at the wrist, on the skin, or subcutaneously, the sensors capture physiological values continuously without the need for blood draws in a laboratory.

Core Measurement Parameters

Modern devices monitor several vital functions simultaneously. The most common measurements are:

  • Heart rate and heart rhythm
  • Blood glucose via continuous glucose monitoring
  • Oxygen saturation (SpO2)
  • Blood pressure measurement and skin temperature

Electrochemical Sensors as Market Drivers

Electrochemical biosensors grow at the fastest rate of 12.1 percent. They held a 23.7 percent market share in 2024, driven by broad adoption of continuous glucose monitoring.

Nano-Biosensors and Their Role

Nano-biosensors increase sensitivity and reduce form factor. These sensors enable diagnostics that were previously only conceivable in clinical settings directly on the body.

The Health Technology Stocks Market in 2026

Those dealing with health technology stocks 2026 encounter a sector with stable, structural growth. Aging populations in developed countries and the prevalence of chronic diseases drive demand persistently.

Key Market Metrics at a Glance

The central metrics demonstrate the segment's potential:

  • Global market value 2024: approx. 31.6 billion US dollars
  • Forecast 2034: approx. 66.2 billion US dollars
  • East Asia market share 2024: approx. 36.5 to 38.5 percent
  • North America market share 2024: approx. 27.5 to 28.6 percent

Regional Growth Markets

East Asia leads the market, particularly Japan with its aging society. The Japanese market is expected to grow from 2.9 billion US dollars (2024) to 6.6 billion US dollars (2034), at a growth rate of 8.5 percent.

Why the Sector Grows Structurally

Remote patient monitoring and integration with telehealth platforms accelerate adoption. The lasting effects of the COVID-19 pandemic have anchored digital health solutions in medical practices and households.

Pure Biosensor and Medical Technology Stocks

Specialists benefit directly from growth but carry higher individual risk. Those investing strategically in medical technology stocks should track companies' regulatory pipelines.

Dexcom as CGM Market Leader

Dexcom Inc. (DXCM) holds approximately 74 percent of the US continuous glucose monitoring market. Products like Dexcom G7 and the G7 15 Day extend wear duration to over 15 days. In March 2025, the company received an FDA warning letter due to manufacturing deficiencies.

Abbott and the Over-the-Counter Turn

Abbott Laboratories (ABT) operates the FreeStyle Libre system. In June 2024, the manufacturer received FDA approval for Libre Rio, an over-the-counter CGM system. This opens direct consumer access without a doctor's prescription.

Medtronic, iRhythm, and Lantheus Holdings

Medtronic plc (MDT) supplies Guardian Connect sensors and MiniMed systems. iRhythm Technologies (IRTC) develops wearable biosensors for diagnosing heart rhythm disorders. Lantheus Holdings expands the field of imaging and diagnostic health technology. These stocks react strongly to individual approval decisions.

Apple Health Technology in Investment Focus

Apple Inc. (AAPL) combines hardware, software, and services into a closed ecosystem. The Apple Watch measures heart rate, SpO2, and ECG. For investors, Apple Health Technology is less a pure biosensor business than a component of a broad technology conglomerate.

What the Health App Can Do

The Health App aggregates performance data from smartwatch, smartphones, and connected devices. Users see trends in sleep, activity, and heart health in one place. Features include notifications for irregular heart rhythm and fall detection.

How Cardiologists Assess the Measurements

The Apple Watch ECG function can detect signs of atrial fibrillation but does not replace clinical diagnostics. Doctors use the data as a complementary indicator, not as a sole basis for decisions.

Costs and Usage

The Health App itself is free and comes preinstalled on every compatible iPhone. Costs arise from devices and optional services. For stock valuation, the revenue from the services segment counts most, which grows steadily.

Samsung Wearables and the Galaxy Ecosystem

Samsung Electronics integrates health sensors into the Galaxy lineup. Samsung wearables such as the Galaxy Watch measure heart rate, blood pressure, and body composition. For investors, Samsung is a diversified electronics conglomerate with a relevant health segment.

The Galaxy Wearable App

The Galaxy Wearable App connects smartwatch and smartphones and controls device settings. It is available free in the Galaxy Store and Google Play. The app synchronizes performance data and enables notification management.

What the App Is Used For

Without the Galaxy Wearable App, a Galaxy Watch cannot be fully set up. It provides the user manual, manages watch faces, and pairs sensors with the smartphone. Users can find details on compatibility and setup directly via samsung.com.

Google and the Android Foundation

Google provides Wear OS, the platform on which many Samsung wearables run. The close integration of Samsung and Google influences features, updates, and the use of health services.

Suppliers and Component Manufacturers

Behind every wearable are sensors and chips. Suppliers benefit across industries from growth without bearing the end-consumer risk of a single product.

Infineon, Texas Instruments, and TDK

Infineon Technologies AG (IFX) supplies sensor technology from Germany. Texas Instruments (TXN) produces semiconductors for biosensors. TDK Corporation manufactures sensor components. These companies form the technical backbone of the market.

Philips and Broadcom

Koninklijke Philips N.V. (PHG) develops medical technology wearables. Broadcom Inc. (AVGO) manufactures sensor chips. Both serve multiple customers and thus diversify their business risk.

The Role of Artificial Intelligence

Algorithms evaluate sensor data and recognize patterns before symptoms appear. The combination of artificial intelligence and biosensors shifts the market from pure measurement to prediction.

Predictive Health Models

Penn State received an NSF grant of 1.5 million US dollars in October 2024 to develop AI-enabled biosensors. Such early warning systems are to detect diseases before they show clinically.

Real-time Monitoring as Standard

Real-time monitoring transforms point measurements into continuous data streams. These solutions enable personalized applications that adapt to the wearer's lifestyle.

Industry Trends in Detail

Several developments shape the sector beyond pure revenue growth.

Over-the-Counter Access and Longer Runtimes

Libre Rio and Dexcom's Stelo biosensor open the market to consumers without prescriptions. Simultaneously, manufacturers extend wear duration, reducing cost per day.

Femtech and New Applications

Global femtech investments exceeded three billion US dollars annually in the mid-2020s. Hormone-monitoring sensors form a separate growth segment. Environmental and food monitoring also use the technology.

Online Sales

Around 35 percent of health-conscious buyers preferred digital purchase of wearable biosensors in 2024. The shopping cart increasingly shifts to online channels.

Sector Challenges

Despite growth, risks remain concrete and should factor into valuation.

Costs and Regulatory Hurdles

High product costs burden many patients. FDA and EMA approvals determine market entry, and quality deficiencies lead to warnings. Production under strict requirements ties up significant resources.

Accuracy and User Knowledge

Sensor placement strongly influences accuracy. FreeStyle Libre sensors work reliably on the upper arm but insufficiently on the abdomen. Lack of user knowledge also diminishes the practical value of devices.

Competition and Patent Risks

Traditional point-of-care biosensors continue to enjoy trust among professionals. Patent disputes harbor both opportunities and risks. Companies without yearly iteration lose customers to competitors with better battery life.

ETFs as Broad Access

Those wishing to diversify individual risk find segment access via ETFs. Health and technology ETFs bundle many stocks in one fund.

Advantages of Diversification

ETFs smooth fluctuations of individual stocks. A mix of pure biosensor firms and broad technology conglomerates noticeably reduces clustering risk.

What to Watch for in Selection

Check composition, ongoing costs, and the fund's currency. A US-heavy ETF brings currency risk that changes returns in euros.

How Investors Approach the Topic via aktie.com

On aktie.com, users track over 10,000 assets in real time, including stocks, ETFs, and other instruments. Daily analyses and guides classify developments in the health sector.

Data and Tools

The cockpit consolidates price data, metrics, and estimates clearly. The AI financial assistant answers questions about individual stocks and analyzes risks based on current values.

Learning and Classification

Knowledge modules explain basics from stocks to ETF savings plans. The portfolio simulator enables backtesting and a diversification score before real capital flows.

Our Three-Step Framework for Company Valuation

To classify wearable biosensors stocks, we use a clear approach in our analyses.

Step 1: Examine Business Model

Is the company a pure specialist or a broad conglomerate? Specialists grow faster but fluctuate more. Check revenue, profit, and the fiscal year.

Step 2: Pipeline and Approvals

Approvals are price triggers. Track the regulatory pipeline and the fiscal year-end when companies publish performance data.

Step 3: Competition and Differentiation

Assess technological advantages such as longer runtimes or multi-analyte capability. Companies with clear differentiation defend margins better.

Practical Access Through a Broker

Purchasing individual stocks or ETFs goes through a broker. Compare fees, available trading venues, and settlement in the respective currency.

Compare Portfolio Features

Watch for portfolio functions like savings plans, limit orders, and an overview of your holdings. Many providers bundle mobile services in an app for on-the-go.

Costs and Transparency

Order fees and spreads reduce returns. Read the terms and privacy policy before opening an account.

Reliable Sources for Classification

For up-to-date prices and metrics, established financial portals such as finanzen.net provide a solid foundation. Supplementary industry overviews help compare trends across multiple segments.

Reading Metrics Correctly

Earnings per share, revenue growth, and forecasts for the coming fiscal year hint at valuation. A symbol or ticker uniquely identifies each security.

Further Topics

Those examining leverage products find a classification under Derivatives simply explained. Tax aspects are covered in the article on Tax classes in Germany.

Frequently Asked Questions

What Role Does North America Play in the Market?

North America held approximately 27.5 to 28.6 percent of the market in 2024, supported by strict regulation, advanced research, and clinical integration.

Why Does the Health App Sometimes Not Work?

Usually it is due to missing permissions, outdated software version, or broken pairing between smartphone and smartwatch. A restart and update often fix the errors.

Is the Galaxy Wearable App Free?

Yes. The app is available free in the Galaxy Store and Google Play and is required for setting up a Galaxy Watch.

Are Individual Stocks or ETFs Better Suited?

Individual stocks offer higher chances at higher risk. ETFs diversify across many companies and suit investors wanting broad segment coverage.

What Trends Drive Growth in 2026?

Over-the-counter access, longer sensor runtimes, artificial intelligence integration, and demand in East Asia rank among the strongest drivers.

Classification for Your Own Strategy

The sector offers structural growth but demands patience and clear risk diversification. Those combining specialists, broad companies, and suppliers cover different parts of the value chain. aktie.com offers no investment advice; all information is provided for information only and without warranty.

Sources

Share Article

X LinkedIn
Comments (0)

Sign in to comment.

You might also be interested in

Subscribe to newsletter

Get the most important market updates and analyses delivered to your inbox.